Background Two objectives of the NIMH Research Domain Criteria (RDoC) initiative are to
identify (a) mechanisms that are common to multiple psychiatric disorders, and (b) …

Background Whilst cannabis use appears to be a causal risk factor for the development of
schizophrenia-related psychosis, associations with mania remain relatively unknown. This …

The British Association for Psychopharmacology guidelines specify the scope and targets of
treatment for bipolar disorder. The third version is based explicitly on the available evidence …

Abstract The British Association for Psychopharmacology guidelines specify the scope and
target of treatment for bipolar disorder. The second version, like the first, is based explicitly …

The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) was
conceived in response to a National Institute of Mental Health initiative seeking a public …

By considering the debilitating outcome of co-occurring of bipolar disorder (BD) and
substance abuse, determination of risk factors of substance use disorders (SUD: abuse or …

Abstract Background Substance use disorders (SUDs) are common in people with a bipolar
disorder (BD). This systematic review and meta-analysis aimed to estimate the prevalence …

A thoroughly updated version of a key practitioner text, this new edition includes a treatment
manual of cognitive-behavioural therapy for Bipolar Disorder which incorporates the very …

Background Comorbidity between substance use disorders (SUDs) and bipolar disorder
(BD) is highly prevalent to the extent it may almost be regarded the norm. This systematic …

The British Association for Psychopharmacology guidelines specify the scope and target of
treatment for bipolar disorder. They are based explicitly on the available evidence and …